Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Eat Well Investment Group Inc EWGFF


Primary Symbol: C.EWG Alternate Symbol(s):  C.EWG.WT

Eat Well Investment Group Inc. is a Canada-based plant-based food investment company. The Company is focused on agribusiness, foodtech, and consumer packaged goods (CPG) brands. It offers the opportunity to invest in the entire plant-based supply chain, from seed-to-market, not a single brand or a single piece of the value chain. Its subsidiaries include Sapientia Technology LLC (Sapientia), Belle Pulses Ltd. (Belle Pulses), and Belle Pulses USA LLC (Belle Pulses USA). Its subsidiaries are at the forefront of processing, distributing, and marketing plant-based foods. With its family of private labels and owned brands, including Sapientia, Belle Pulses, and Eat Well, the Company is engaged in feeding families worldwide. Sapientia is primarily involved in the development of intellectual property (IP) in the savory snacking sector. Belle Pulses is a pulse processor in Canada. It produces a variety of pulse products to meet the demanding ingredient needs of the food industry globally.


CSE:EWG - Post by User

Post by tinkvidon Apr 29, 2021 9:50am
285 Views
Post# 33090136

Rockshield Capital Announces Renewal of Normal Course Issuer

Rockshield Capital Announces Renewal of Normal Course Issuer
Interesting.....

They have rebranded their site and good to see the core Directors still involved.

 
2021-04-29 07:01 ET - News Release
 
 
Vancouver, British Columbia--(Newsfile Corp. - April 29, 2021) - Rockshield Capital Corp. (CSE: RKS) (OTC Pink: RKSCF) (FSE: 6BC) (the "Company") announces that it intends to renew its normal course issuer bid ("NCIB") through the facilities of the Canadian Securities Exchange. Under the NCIB, the Company intends to acquire up to 4,473,534 common shares (the "Shares") in the capital of the Company, representing approximately 5% of its current public float. As at April 28, 2021, the Company had 89,470,687 common shares issued and outstanding. The normal course issuer bid will commence on April 30, 2021 and end no later than April 30, 2022. The Company may terminate the NCIB earlier if it feels it is appropriate to do so.
 
The Company has appointed PI Financial Corp. to conduct the NCIB. The purchase and payment of the Shares will be made in accordance with all requirements of the CSE. All price paid for the Shares will be the market price at the time of purchase. All Shares purchased will be cancelled.
 
The Company is commencing the NCIB because it believes that the current market price of its common shares may not fully reflect the underlying value of the Company's business and future prospects.
 
ROCKSHIELD CAPITAL CORP.
 
Rockshield is an investment company primarily focused on high-growth companies in the plant-based, renewal energy, and ESG sectors. The Company has signed a Letter of Intent to acquire 100% of one of Canada's largest pulse crop processors, 100% of Sapientia Technology Corp., a leading plant-technology company with over 25 patents, and 75% of BOKU Superfoods, a plant-based superfoods company. Rockshield's management team has an extensive track record of sourcing, financing, and building successful companies across a broad range of industries and maintains a current investment mandate on the health and wellness industry. The team has financed and invested in early-stage venture companies for over 25 years resulting in unparalleled access to deal-flow and the ability to construct a portfolio of opportunistic investments intended to generate superior risk-adjusted returns.
 
For further information regarding Rockshield, see Rockshield's disclosure documents on SEDAR at www.sedar.com.
 
Contact Information
 
Rockshield Capital Corp.
Investor Relations
ir@rockshield.ca
<< Previous
Bullboard Posts
Next >>